Looking for a perfect biotech company with no problems whatsoever? Sorry, but Source: Shutterstock  (NASDAQ:LGVN) doesn’t fit that description. However, it’s definitely safe to say that LGVN stock is on a powerful upward trajectory that could last for quite a while. If the trend is your friend, then Longeveron’s among the friendliest names on Wall…

Autodesk (NASDAQ:ADSK) stock is taking a beating on Wednesday after the software company reported mixed earnings for its fiscal third quarter of 2022. Source: JHVEPhoto / Shutterstock.com Let’s get the positive news out of the way first. Autodesk reported adjusted earnings per share of $1.33 on revenue of $1.13 billion. Both of these are better…

One of the biggest moves in the market today belongs to Longeveron (NASDAQ:LGVN). Currently, LGVN stock is up approximately 180% on more than 100 times the average daily volume. Source: luchschenF / Shutterstock.com This sort of outsized move is one that ought to grab investor’s attention. As a clinical-stage biotech company, volatility can be expected.…

I don’t get my investment advice from Robert Kiyosaki, the famous (or infamous) author of the Rich Dad, Poor Dad series of books. However, I can understand his latest cause for concern regarding the supposed global asset bubble. Particularly, with property developer China Evergrande (OTCMKTS:EGRNF) shares joining the ranks of literal penny stocks, it may…

This article is excerpted from Tom Yeung’s Moonshot Investor newsletter. To make sure you don’t miss any of Tom’s potential 100x picks, subscribe to his mailing list here. Insider Buying Continues Source: Chad McDermott / Shutterstock.com Last week’s newsletter about insider buying seems to have struck a chord with the Moonshot community: Outrage. “How do…